- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical
- Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
- Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
More ▼
Key statistics
On Friday, Haemonetics Corp (HAE:NYQ) closed at 81.24, 14.84% above the 52 week low of 70.74 set on Feb 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 83.32 |
---|---|
High | 83.32 |
Low | 80.15 |
Bid | 80.78 |
Offer | 81.54 |
Previous close | 83.46 |
Average volume | 450.01k |
---|---|
Shares outstanding | 50.79m |
Free float | 50.40m |
P/E (TTM) | 33.77 |
Market cap | 4.24bn USD |
EPS (TTM) | 2.47 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 21:10 BST.
More ▼